Heron Therapeutics | HRTX - Deudores Comerciales

Precio De Mercado
0.80
Cambio Diario
0.02 2.05%
Mensual
-27.06%
Anual
-67.28%
Q1 Expectativa
0.76




Deudores Comerciales Cambio Fecha
ALKERMES USD 334.02M 21.08M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 126.83M 477K 2025-12
ANI Pharmaceuticals USD 281.08M 28.46M 2025-12
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Eisai JPY 249.06B 25B 2025-12
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Esperion Therapeutics USD 140.19M 21.21M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
Merck USD 12.12B 596M 2025-09
Nektar Therapeutics USD 0 2.9M 2024-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Omeros USD 8.08M 440K 2024-06
Pacira USD 124.07M 8.8M 2025-12
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Surmodics USD 23.27M 790K 2024-09
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Veracyte USD 44.66M 3.17M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12